India  

Adar Poonawalla

Indian businessman

Adar Poonawalla    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Adar Poonawalla: Indian businessman
Adar Poonawalla is the chief executive officer (CEO) of Serum Institute of India. Founded in 1966 by his father, Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.

0
shares
ShareTweetSavePostSend
 

You Might Like


Serum Institute of India to launch indigenously made vaccine to treat cervical cancer

Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year.
IndiaTimes - Published

Covid-19 vaccine Covovax now available for children in India: Adar Poonawalla

Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the Covid-19 vaccine Covovax is now available in India for children. He also hailed PM Narendra Modi for his vision of providing..
IndiaTimes - Published

Covid 4th wave: Adar Poonawalla warns against 'business as usual' approach amid rising cases

Though the government, as a whole, recognises the importance of healthcare, it seems the urgency has been lost, Adar Poonawalla said.
DNA - Published

Indian Covid vaccines better than Pfizer, Moderna: Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and..
IndiaTimes - Published

Reduce time gap for Covid vaccine booster dose to six months: Serum Institute to govt

Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to six months from nine months at present to safeguard people against..
IndiaTimes - Published

Serum Institute of India prices Covishield booster dose at Rs 600

SII CEO Adar Poonawalla also welcomed the government's move to allow precautionary doses of the vaccine to all aged above 18 years.
DNA - Published

Serum Institute has applied for full market authorisation of Covishield: CEO Adar Poonawala

Serum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla..
IndiaTimes - Published

SII CEO Adar Poonawalla makes BIG announcement on COVID-19 vaccine for children

Serum Institute's CEO Adar Poonawalla has said that the vaccine for children will most likely be launched within six months.
DNA - Published

Not enough orders, may cut Covishield output by 50%: SII

With not enough orders for Covishield from the Centre, Serum Institute of India CEO Adar Poonawalla on Tuesday said the company is looking at slashing monthly production of vaccines by at least 50% %...
IndiaTimes - Published

How effective is Covishield against Omicron? SII CEO Adar Poonawalla says this

In India, no cases of the new variant have been detected yet, but the government says it is preparing to deal with it.
DNA - Published

'Vaccine hesitancy biggest threat': SII CEO Adar Poonawalla on COVID-19

The government will soon launch a door-to-door vaccination campaign so that no adults are left of vaccination and are covered by next month.
DNA - Published

Covid-19 vaccine hesitancy greatest threat in overcoming pandemic, says Adar Poonawalla


IndiaTimes - Published

Will have enough doses for booster shots, says Poonawalla

Adar Poonawalla, CEO of Serum Institute of India (SII), exuded confidence in meeting the Centre’s goal of immunising all adults by yearend, while announcing that Covid-19 vaccine for children,..
IndiaTimes - Published

Serum Institute could export 20-30 million vaccine doses a month to Covax, says Adar Poonawalla


IndiaTimes - Published

PM Modi, Mamata and Adar Poonawalla among Time Magazine's 100 'most influential people of 2021'

Prime Minister Narendra Modi, West Bengal chief minister Mamata Banerjee and Serum Institute of India CEO Adar Poonawalla have been named among the world's 100 most influential people of 2021 by TIME..
IndiaTimes - Published

Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEO Adar Poonawalla


IndiaTimes - Published

15 of 27 member countries of the EU have approved Covishield: Poonawalla


IndiaTimes - Published

Adar Poonawalla says EU green pass Covishield issue has been ‘blown out of proportion’

Serum Institute of India CEO Adar Poonawalla played down on Wednesday Covishield not getting approved for the EU green pass, saying, "It is not a controversy at all. It’s been blown out of..
IndiaTimes - Published

'Matter of time': SII's Poonawalla confident of getting EU green pass for Covishield

Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said that the European approval for its locally manufactured Covishield vaccine is "just a matter of time" and is expected in about a..
IndiaTimes - Published

Serum Institute CEO Adar Poonawalla breaks silence on India's Covishield yet to get European Union 'Green Pass'

Indians who are vaccinated with the Covishield may not be eligible for the European Union's 'Green Pass', according to reports.
DNA - Published

Poonawalla tells Bombay HC he seeks no Z-Plus cover, nor endorses any plea on his behalf; petition disposed


IndiaTimes - Published

Poonawalla thanks Biden, Jaishankar for policy change to boost vaccine production


IndiaTimes - Published

Covid-19: Didn't export vaccines at the cost of the people in India, says Adar Poonawalla


IndiaTimes - Published

Serum Institute CEO Adar Poonawalla finally breaks silence on export of vaccines

"Our government extended support wherever possible during this period," Serum Institute said in a statement.
DNA - Published

Plea in Bombay HC seeks Z-plus security for SII CEO Adar Poonawalla


IndiaTimes - Published

Not possible to ramp up vaccine production overnight: SII CEO Adar Poonawala

Serum Institute of India (SII) CEO Adar Poonawala on Monday said it is not possible to ramp up vaccine production overnight.Amid the ferocious second wave gripping India, Poonawala said "vaccine..
IndiaTimes - Published

Congress assures security to Adar Poonawalla, urges him to name leaders who made threat calls

Maharashtra Congress chief Nana Patole urged Poonawalla to make the names of those leaders public, adding that his party takes full responsibility for his security.
IndiaTimes - Published

Serum Institute CEO Adar Poonawalla: Will return to India in a few days

"Had an excellent meeting with all our partners & stakeholders in the UK. Meanwhile, pleased to state that Covishiled's production is in full swing in Pune. I look forward to reviewing operations upon..
IndiaTimes - Published

Serum Institute of India CEO Adar Poonawalla flies to London to after receiving 'threats' from CMs, corporates leaders

Poonawalla said that he is planning to stay in the UK for a long time because of constant threats he's getting from CMs and other corporate leaders.
DNA - Published

Covishield production in full swing, says SII's Adar Poonawalla


IndiaTimes - Published

'Getting aggressive calls from powerful people': Serum CEO Adar Poonawalla on vaccine pressure

Referring to the phone calls, Poonawala said "Threats is an understatement. The level of expectation and aggression is really unprecedented. It's overwhelming. Everyone feels they should get the..
IndiaTimes - Published

Serum Institute plans to start Covid vaccine production outside India: Report

The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief..
IndiaTimes - Published

Serum Institute CEO Adar Poonawalla gets 'Y' category security cover


IndiaTimes - Published

Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per dose

Serum Institute of India on Wednesday announced that it was reducing the price of its Covishield vaccine from Rs 400 to Rs 300 per dose for the states as a "philanthropic gesture". "As a philanthropic..
IndiaTimes - Published

Covid-19: Most vaccines may cost 700-1,000 per dose

Most companies are expected to price the Covid-19 vaccines around Rs 700-1,000 per dose, when they roll out the jabs in the private market later this year, up from the government-mandated price of Rs..
IndiaTimes - Published

Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla

Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of Covid-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year.
IndiaTimes - Published

Adar Poonawalla urges countries to be patient, says Serum directed to prioritise India needs

Adar Poonawalla, CEO of vaccine major Serum Institute of India (SII), on Sunday urged other countries to be patient as they wait for the supplies of Covid-19 vaccine, Covishield, as the company has..
IndiaTimes - Published

India's Serum says will ship AstraZeneca vaccine to Canada in 'less than a month'

The Serum Institute of India will ship the Oxford University/AstraZeneca Covid-19 vaccine to Canada in less than one month, Serum's chief executive said on Monday. "As we await regulatory approvals..
IndiaTimes - Published

Serum Institute of India plans to launch Covovax by June: Adar Poonawalla

SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India. Hope to launch..
IndiaTimes - Published

COVID-19: Is India to get one more coronavirus vaccine, here's what SII CEO Adar Poonawalla said

The vaccine is being developed in partnership with American vaccine developer Novavax.
DNA - Published

Serum Institute applies to conduct local trial for Novavax vaccine: CEO

The Serum Institute of India (SII), the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc's COVID-19 vaccine, which was found to be 89.3%..
IndiaTimes - Published

SII to send 3m Covid shots to Saudi in a week: Poonawalla


IndiaTimes - Published

Serum fire losses pegged at over Rs 1,000 crore; Covid vaccine supplies safe

Serum Institute of India (SII) CEO Adar Poonawalla on Friday said its manufacturing plant at Manjari here suffered a loss of over Rs1,000 crore in Thursday’s fire that claimed five lives.
IndiaTimes - Published

Serum Institute fire: Vaccine supply won't be affected, says CEO Adar Poonawalla


IndiaTimes - Published

Serum Institute fire: Adar Poonawalla explains why he tweeted, 'no lives lost'

Adar Poonawalla has given an explanation on his tweet that he did after fire broke out at Serum Institute's facility in Pune on Thursday afternoon.
DNA - Published

Adar Poonawalla reassures Covishield production won't be affected, tweets 'no lives lost' in SII fire

A major fire broke out at a building inside Terminal Gate 1 of the Serum Institute of India (SII) in Maharashtra's Pune on Thursday afternoon.
DNA - Published

COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price here

Serum Institute of India CEO Adar Poonawalla on Tuesday (January 12) said that 'Covishield' will be made available in private markets at Rs 1,000.
DNA - Published

Covishield to cost Rs 1000 per vial in private market: SII CEO Adar Poonawalla

"We have given a special price of Rs 200 for the first 100 million doses only to the Government of India on their request, because we want to support common man, vulnerable, poor and healthcare..
IndiaTimes - Published

Brazil dials India on Covid vaccine imports

India’s vaccine diplomacy push might be impacted by confusing signals on the export of vaccines. On Monday, the Jair Bolsonaro government in Brazil dialled the Indian government after the chief of..
IndiaTimes - Published

Private hospitals, companies may get vaccine by March: Serum CEO

SII, once it rolls out the 50-60 million doses of Covishield that forms the first tranche of the govt's order, will give doses to private individuals, private hospitals and companies as early as March,..
IndiaTimes - Published


 Page 1  〉